Issue #160
- ddI: FDA Approves Additional Indication
- Rifabutin: FDA Advisory Committee Recommends for MAC Prophylaxis
- International Conference and Clinical Practice: Interview with Kenneth Mayer, M. D.
- 566C80 (Atovaquone): FDA Advisory Committee Recommends Approval for Pneumocystis Treatment
source: AIDS Treatment News
